News About: R&D
Icure acquires approval of Phase 3 clinical trial of donepezil patches for the first time
Icure, a pharmaceutical R&D company owning the original technology of the Transdermal Drug Delivery System(TDDS) and having the largest market share in the donepezil market, acquired approval for the Phase 3 clinical ...
What is the current trend for ‘anticancer’ clinical pipelines?
Approaches for R&Ds, including Open Innovation, have never been more diversified over new drug candidates. Domestic pharmaceutical companies are also racing to strengthen their new drug pipelines to follow the trend.
...
R&D investments of listed pharmaceutical companies remain unchanged
R&D investments of listed pharmaceutical companies have remained unchanged.
According to the analysis result of 3rd quarter’s performance reports of KOSPI and KOSDAQ listed pharmaceutical companies in 2015, the ratio...
Will newly-joined domestic pharmaceutical companies be successful in DPP-4 diabetic treatment market?
The DPP-4 inhibitor diabetes treatment market, which has been occupied by Januvia and Trajenta, has recently been invaded by domestic pharmaceutical companies.
Handok has made progress in commercializing ambitiously ...
Emergence of Treatment for multiple sclerosis patients failed in treatment
Multiple sclerosis(MS) patients who failed in treatment have now found an alternative.
The Ministry of Health and Welfare decided to accept the health insurance benefit of Genzyme’s ‘Lemtrada(alemtuzumab)’ on relapsi...
Supported by Samsung, a new era with MERS vaccine has begun
The International Vaccine Institute(IVI, Director General Jerome Kim) will hold the ‘2015 Sinil-IVI Global Vaccine Forum: International MERS-CoV Symposium’ at Novotel Ambassador Gangnam on the 10th. In order to develo...
The R&D investment of the pharmaceutical industry has been heated up
R&D investment of pharmaceutical companies has been heating up. Large pharmaceutical companies, in particular, are leading the phenomenon. On the other hand, mid-sized pharmaceutical companies seem to have hard time i...
Korea ranked 2nd in stem cell treatment clinical trials in the world
It is known that Korea ranked the 2nd in the number of clinical trials for stem cell treatments.
National Institute of Food and Drug Safety Evaluation, the Ministry of Food and Drug Safety announced on the 7th that i...
A type B hemophiliac treatment acquired the selling approval after the launch of the Benefix 10 years ago
A competing product of the only type B hemophiliac treatment launched in Korea, Benefix, is expected to be launched.
It has been 10 years since the launch of Benefix.
On the 6th, the Ministry of Food and Drug Safety...
There were 33,540 pharmaceutical patents in Korea for the past 7 years
The Korea Health Industry Development Institute (KHIDI)recently released a report titled ‘Trend Analysis Regarding the Healthcare Industry Using Domestic Patent Information’publicize the domestic pharmaceutical patent...
